Free Soft Tissue Graft in Treatment of Oral Lichen Planus
TOLP
1 other identifier
interventional
20
1 country
1
Brief Summary
Oral lichen planus is a common chronic mucocutaneous disease with various clinical forms. Erosive-ulcerative forms usually cause symptoms of pain and discomfort. The most important complication of OLP is development of oral squamous cell carcinoma, although this is a very controversial matter. various treatments have been suggested for OLP but their results are unsatisfactory. Through the experiences of the investigators, corticosteroids (in any form)is not a wise option for treating OLP and has many side effects . More over, immunosuppressive therapy did not influence the risk for oral cancer. The purpose of the study is to determine the efficacy of free soft tissue graft in the treatment of precancerous and symptomatic lesions of OLP. Removal of the lesions up to submucosa has been done. The graft sliced from healthy mucosa also up to submucosa. Then graft will be sutured in position. According to other authors, basal epithelial layers of the graft remain intact and represent the focus of re-epithelization. New epithelial cells migrate over the basal membrane and appear to guide it by proliferation, will generate new epithelium. The wound is re-epithelialized by proliferation of surrounding healthy epithelial cell, therefore, not contaminated by modified antigens of the cell membrane that are theoretically responsible for lymphocyte aggression. The healthy graft remains free of lesions and appears clinically healthy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started May 2008
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 18, 2008
CompletedFirst Posted
Study publicly available on registry
August 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedDecember 11, 2008
August 1, 2008
2 years
August 18, 2008
December 9, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relief of sign & symptoms (every 2 month up to 1 years)
1 year
Secondary Outcomes (1)
Relief of sign & symptoms and no positive histopathologic features of OLP
(time frame 1 years)
Study Arms (1)
1 ARM
EXPERIMENTALOtherwise healthy patients with oral lichen planus (precancerous/erosive OLP)
Interventions
20 patients with OLP will be selected for this study. Before this routine treatment modalities had been attempted. Removal of possible triggering drug was also considered. Local ethical committee approval will be obtained before the trial starts. Surgical procedure includes: removal of the tissue up to submucosa (containing antigenic properties that caused OLP). A specimen will be sent for histopathologic analysis. The graft sliced from healthy mucosa also up to submucosa. Then the graft trimmed on a gauze soaked in saline and adapted to recipient site. The graft was sutured in position. Checking will be done after 1 week and every two months up to 1 year. Punch biopsy will be done in 1 year after surgery for histopathologic investigations.
Eligibility Criteria
You may qualify if:
- Biopsy confirmed symptomatic oral lichen planus: WHO histological criteria in combination with clinical appearance will be used for diagnosis
- Previous routine treatment modalities has been attempted including steroids and immunomodulatory or antioxidant agents. i.e patients who had resistant lesions to routine treatment .removal of possible triggering drugs was also considered.
- Patients of both sexes between 40 to 70 year's old
- Patients who have symptoms such as burning sensation, pain
- Patients who have localized precancerous lesions such as atrophic-erosive/plaque like lichen planus with diameter lesser than 2 cm
- Patients who agree to this treatment
- Patients who are willing for evaluation in first week after surgery and every two month for 1 years
- Patients who agree to final punch biopsy for histopathologic evaluation
You may not qualify if:
- Patients who unable to undergo oral surgery
- Patients suffering from any localized or systemic disease
- Pregnant patients
- Smokers
- Patients who can not continue the study for private or social reasons
- Patients with generalized oral lichen planus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qazvin University of Medical Sciences
Qazvin, Qazvin State, 3415759811, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Farshid Rayati, DDS
Qazvin University Of Medical Sciences
- PRINCIPAL INVESTIGATOR
Tuba(Aida) Karagah, DDS
QUMS
- STUDY CHAIR
Farshid Rayati, DDS
QUMS
- STUDY CHAIR
Saeid Asefzadeh, PHD
QUMS
- STUDY DIRECTOR
Poopak masumi, DDS-MS
QUMS
- PRINCIPAL INVESTIGATOR
pourya falah, student
QUMS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 18, 2008
First Posted
August 20, 2008
Study Start
May 1, 2008
Primary Completion
May 1, 2010
Study Completion
December 1, 2010
Last Updated
December 11, 2008
Record last verified: 2008-08